[144] TAT TECHNOLOGIES LTD SEC Filing

Rhea-AI Filing Summary

TAT Technologies Ltd (TATT) filed a Form 144 notifying the proposed sale of 7,706 ordinary shares through Oppenheimer & Co. Inc., with an aggregate market value of $298,992.80. The shares represent approximately 0.07% of the 10,940,358 shares outstanding and are scheduled for sale on 09/17/2025 on NASDAQ. The filer acquired the securities on 03/06/2017 under an employee stock option plan and intends to pay cash upon exercise. The filing reports no sales by the same person in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• Regulatory compliance: The filer provided required disclosure details including acquisition date, broker, sale date, and attestation.
• Transparency: No related sales in the past three months were reported, reducing ambiguity about concentrated insider selling activity.

Negative

• Insider sale announced: An insider plans to sell 7,706 shares, which could be perceived negatively by some investors despite its small size relative to outstanding shares.

Insights

Securities Analyst

TL;DR: Routine insider notice of a small equity sale; limited market impact given size relative to shares outstanding.

The Form 144 reports a proposed sale of 7,706 ordinary shares valued at $298,992.80, acquired under an employee stock option plan in 2017. The shares equal roughly 0.07% of the outstanding share count, indicating the transaction is immaterial to overall equity supply and unlikely to meaningfully affect market price. The sale will be executed through a broker on NASDAQ and the filer attests to no undisclosed material information. From a market-impact perspective this is a standard compliance filing rather than a signal of company-level change.

Corporate Governance Expert

TL;DR: Filing meets disclosure requirements for an insider sale; customary representation included.

The notice discloses acquisition date, nature of acquisition (employee stock option plan), intended broker, sale date, and payment method (cash upon exercise). It also states there were no related sales in the prior three months and contains the required attestation regarding material adverse information. These elements align with expected governance and regulatory transparency for insider transactions, offering investors documented visibility into executive/insider liquidity actions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	7706	298992.80	10940358	09/17/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	03/06/2017	Employee Stock Option Plan	From the Issuer			7706	09/17/2025	Cash - Upon Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did TAT Technologies (TATT) disclose in this Form 144?

The filer disclosed a proposed sale of 7,706 ordinary shares valued at $298,992.80, to be executed on 09/17/2025 through Oppenheimer & Co. Inc. on NASDAQ.

How were the shares acquired that are being sold?

The shares were acquired on 03/06/2017 under an employee stock option plan from the issuer.

What portion of TATT's outstanding shares does this sale represent?

The 7,706 shares equal approximately 0.07% of the reported 10,940,358 shares outstanding.

Will the filer be paid in cash or other consideration?

Payment is indicated as cash - upon exercise according to the filing.

Were any other shares sold by this person in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.